Allo-hMSC

bone marrow-derived human mesenchymal stem cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allo-hMSC, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject

See pricing